Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNT/β-catenin pathway and circadian rhythms in obsessive-compulsive disorder. | Neural Regen Res | 2022 | 35259818 | PubTator, text mining | PubMed |
| Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension. | JACC Basic Transl Sci | 2022 | 35257044 | PubTator, text mining | PubMed |
| Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist. | Sci Rep | 2022 | 35256673 | PubTator, text mining | PubMed |
| Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre. | Bone Rep | 2022 | 35252483 | PubTator, text mining | PubMed |
| Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review. | Front Cardiovasc Med | 2022 | 35252378 | PubTator, text mining | PubMed |
| Effects of Mechanical Stress Stimulation on Function and Expression Mechanism of Osteoblasts. | Front Bioeng Biotechnol | 2022 | 35252138 | PubTator, text mining | PubMed |
| Hydrostatic Pressure Controls Angiogenesis Through Endothelial YAP1 During Lung Regeneration. | Front Bioeng Biotechnol | 2022 | 35252132 | PubTator, text mining | PubMed |
| MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy. | Cancer Cell Int | 2022 | 35248049 | PubTator, text mining | PubMed |
| Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia. | Orphanet J Rare Dis | 2022 | 35246174 | PubTator, text mining | PubMed |
| Identification of Two Novel Variants in the LRP5 Gene that Cause Familial Exudative Vitreoretinopathy. | Genet Test Mol Biomarkers | 2022 | 35244470 | PubTator, text mining | PubMed |
| Human Endometrial Organoids: Recent Research Progress and Potential Applications. | Front Cell Dev Biol | 2022 | 35242764 | PubTator, text mining | PubMed |
| Genetic and clinical determinants of abdominal aortic diameter: genome-wide association studies, exome array data and Mendelian randomization study. | Hum Mol Genet | 2022 | 35234888 | PubTator, text mining | PubMed |
| Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B. | Aging (Albany NY) | 2022 | 35230971 | PubTator, text mining | PubMed |
| Tumor microenvironment pathways: Cross regulation in breast cancer metastasis. | Genes Dis | 2022 | 35224148 | PubTator, text mining | PubMed |
| Chemical Modification of Hyaluronan and Their Biomedical Applications. | Front Chem | 2022 | 35223772 | PubTator, text mining | PubMed |
| Acupuncture as Treatment for Female Infertility: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Evid Based Complement Alternat Med | 2022 | 35222669 | PubTator, text mining | PubMed |
| Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study. | BMC Gastroenterol | 2022 | 35216547 | PubTator, text mining | PubMed |
| Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications. | Int J Mol Sci | 2022 | 35216285 | PubTator, text mining | PubMed |
| Early complementary acupuncture improves the clinical prognosis of traumatic brain edema: A randomized controlled trial. | Medicine (Baltimore) | 2022 | 35212308 | PubTator, text mining | PubMed |
| Functional Validation of Osteoporosis Genetic Findings Using Small Fish Models. | Genes (Basel) | 2022 | 35205324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=47